Switzerland has become the first European county to approve Pfizer's (PFE) Tofacitinib treatment...

|About: Pfizer Inc. (PFE)|By:, SA News Editor

Switzerland has become the first European county to approve Pfizer's (PFE) Tofacitinib treatment for rheumatoid arthritis, which can be used in patients who haven't responded well enough to existing treatments. Tofacitinib has also been authorized in Argentina, Kuwait, the UAE and Russia. The approvals add to those in the U.S. and Japan, where Pfizer plans to launch Tofacitinib with Takeda Pharmaceutical this month. (PR)